indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
all-news

SunAct Cancer Institute, Smita Memorial Hospital Launch CoE for CAR T-Cell Therapy in Kerala

IMT News Desk

The newly launched centre introduces India’s first CAR T-Cell Therapy for solid tumours

SunAct Cancer Institute and Smita Memorial Hospital, founded by Dr Suresh H Advani announced the opening of South India’s premier Centre of Excellence in CAR T-Cell Therapy and Bone Marrow Transplantation at Smita Memorial Hospital in Thodupuzha, Idukki district, Kerala.

The Centre was inaugurated by V Vigneshwari, District Collector and District Magistrate of Idukki, in the presence of Dr Advani, SunAct’s co-founders Dr Vijay Patil and Dr Ashay Karpe, and other dignitaries from the oncology and healthcare ecosystem.

The newly launched centre introduces India’s first CAR T-Cell Therapy for solid tumours. In addition to CAR-T, the centre will offer: - TCR (T-Cell Receptor) Therapies

-  TIL (Tumor-Infiltrating Lymphocytes)

-  Gamma Delta T-Cell Platforms

-  Gene Therapies

-  A dedicated Pediatric Oncology Program

The Centre will also accelerate access to Bone Marrow Transplantation (BMT), clinical trials, and new immunotherapies — reinforcing a shared commitment to next-generation care.

Dr Advani stated, “The new Centre of Excellence represents the next frontier: where science, compassion, and collaboration unite to transform patient outcomes."

Dr Vijay Patil said, “We are honoured to launch the first Centre of Excellence in CAR T-Cell Therapy and Bone Marrow Transplantation in South India. With the visionary guidance of Dr Advani, we are committed to making the most advanced cancer therapies — previously only available in elite global centres — both accessible and affordable for Indian patients."

Dr Ashay Karpe, Co-Founder, SunAct Cancer Institute, noted, “This collaboration is a convergence of cutting-edge science and seasoned clinical wisdom. By combining SunAct’s pioneering Cell and Gene Therapies with Dr. Advani’s clinical legacy and Smita Memorial’s infrastructure, we are setting a new benchmark for how cancer should be treated — precise, humane, and accessible.”

Recommended

Glenmark registers consolidated revenue of Rs 60,469 Mn in Q2FY26

Delhi to host 18th edition of CPHI & PMEC India 2025 from Nov 25 to 27, 2025

Pathkind and WebEngage unite to deliver personalised, data-driven patient experiences

Akums reports consolidated revenue of Rs 1,018 crore in Q2 FY26

Apollo Cancer Centre unveils cellular therapy and blood and marrow transplant centre in Bengaluru

Hester Biosciences posts consolidated net profit of Rs 14.33 Cr for Q2 FY25-26

ENTOD launches LUBRINASE for nasal dryness

OMRON Healthcare announces additional investment in India-based AI medtech startup Tricog Health India

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions